Foundry Partners, LLC Jazz Pharmaceuticals PLC Transaction History
Foundry Partners, LLC
- $1.82 Billion
- Q1 2025
A detailed history of Foundry Partners, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Foundry Partners, LLC holds 86,429 shares of JAZZ stock, worth $11.9 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
86,429
Previous 5,092
1597.35%
Holding current value
$11.9 Million
Previous $627,000
1611.32%
% of portfolio
0.59%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding JAZZ
# of Institutions
564Shares Held
62.3MCall Options Held
563KPut Options Held
79.8K-
Black Rock Inc. New York, NY6.15MShares$846 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$838 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$351 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$350 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$349 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.63B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...